Robert G. Maki

Also affiliated with Cornell University, Kettering University

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “A framework for advancing our understanding of cancer-associated fibroblasts”.

A framework for advancing our understanding of cancer-associated fibroblasts

Nature reviews. Cancer(2020)10.1038/s41568-019-0238-1

N/A

9.0DataRank · unranked

3845 citations

Igor Astsaturov, Edna Cukierman, David G. DeNardo, Mikala Egeblad, Ronald M. Evans +24 more

Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network

Annals of Oncology(2020)10.1016/j.annonc.2020.08.2232

N/A

0.749DataRank · unranked

146 citations

Cristina R. Antonescu, Bodil Bjerkehagen, Judith V.M.G. Bovée, Kjetil Boye, Matías Chacón +43 more

Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma

Nature Communications(2022)10.1038/s41467-022-30496-0

N/A

0DataRank · unranked

194 citations

Narasimhan P. Agaram, Sally E. Trabucco, Victoria Robinson, Richard Ferraro, Sherri Z. Millis +38 more

Ewing sarcoma and related FET family translocation‐associated round cell tumors: A century of clinical and scientific progress

Genes Chromosomes and Cancer(2022)10.1002/gcc.23050

N/A

0DataRank · unranked

15 citations

Patrick J. Grohar, Cristina R. Antonescu, Robert G. Maki

SARC037: Results of phase I study of trabectedin given as a 1-hour (h) infusion in combination with low dose irinotecan in relapsed/refractory Ewing sarcoma (ES).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.11519

N/A

0DataRank · unranked

14 citations

Karla V. Ballman, Rachel S. Heise, John Glod, Mary Frances Wedekind, Leo Mascarenhas +15 more

Histology-Specific Clinical Trial of Lenvatinib and Pembrolizumab in Patients with Sarcoma

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-2519

N/A

0DataRank · unranked

20 citations

Kenneth Seier, Viswatej Avutu, Lauren B. Banks, Jason E. Chan, Ping Chi +20 more

Early, precise, and safe clinical evaluation of the pharmacodynamic effects of novel agents in the intact human tumor microenvironment

Frontiers in Pharmacology(2024)10.3389/fphar.2024.1367581

N/A

0DataRank · unranked

3 citations

Karthik Rajasekaran, Jeffrey Houlton, Gary B. Deutsch, Thomas J. Ow, Robert G. Maki +29 more

SARC037: Phase II results of trabectedin given as a 1-hour (h) infusion in combination with low dose irinotecan in patients (pts) with relapsed/refractory Ewing sarcoma (ES).

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.11508

N/A

0DataRank · unranked

13 citations

Karla V. Ballman, Rachel S. Heise, Leo Mascarenhas, John Glod, Mary Frances Frances Wedekind +14 more

NAB2-STAT6 drives an EGR1-dependent neuroendocrine program in Solitary Fibrous Tumors

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.04.15.589533

N/A

0DataRank · unranked

3 citations

Alexandra Indeglia, Francis J. Picone, Maureen E. Murphy, Cara Cipriano, Robert G. Maki +2 more

High transposable element expression in sarcomas is associated with increased immune infiltrates and improved outcomes including after immunotherapy

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2025-012357

N/A

0DataRank · unranked

1 citations

Martina Bradić, Hyung Jun Woo, Allison L. Richards, Ciara M. Kelly, Mark A. Dickson +17 more

Author response: NAB2-STAT6 drives an EGR1-dependent neuroendocrine program in Solitary Fibrous Tumors

(2025)10.7554/elife.98072.2.sa0

N/A

0DataRank · unranked

0 citations

Alexandra Indeglia, Francis J. Picone, Maureen E. Murphy, Cara Cipriano, Robert G. Maki +2 more